| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5M | — | — |
| Cost of Revenue | $11K | — | +173.2% |
| Gross Profit | $6.5M | — | — |
| R&D Expense | $1.3M | — | -14.9% |
| SG&A Expense | $1.8M | — | -17.7% |
| Operating Income | $3.2M | — | +264.6% |
| Interest Expense | $109K | — | -57.3% |
| Pre-tax Income | $3.8M | — | +273.1% |
| Income Tax | $330K | — | — |
| Net Income | $3.5M | — | +258.1% |
| EPS (Basic) | $0.37 | — | +840.0% |
| EPS (Diluted) | $0.37 | — | +840.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.2M | -37.1% | +10.9% |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $75K | +132.6% | -14.5% |
| Current Assets | $1.7M | -24.6% | -9.2% |
| Total Assets | $27.3M | +11.5% | +4.0% |
| Current Liabilities | $20.0M | -5.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +55.2% |
| Financing Cash Flow | $852K | — | +1703.8% |
| -26.5% |
| Total Liabilities | $21.6M | -0.8% | -38.1% |
| Stockholders' Equity | $5.8M | +108.4% | +167.3% |